Table 1.

Group demographics

	Group 1 No specific anti-BAT preparation	Group 2 Patients were in uptake room 24C for one hour prior to FDG	Group 3 Same preparation as Group 2 plus oral propranolol if applicable one hour prior to FDG
Sex
Female	144 (45%)	159 (46%)	280 (45%)
Male	179 (55%)	186 (54%)	342 (55%)
Diagnosis
LL	155 (48%)	136 (39%)	247 (40%)
Solid Tumor	92 (28%)	117 (34%)	229 (37%)
Other	76 (24%)	92 (27%)	146 (23%)
Age (y) at Time of Scan
0 – 3.9	52 (8%)	46 (7%)	106 (7%)
4 – 7.9	79 (13%)	86 (12%)	107 (7%)
8 – 11.9	73 (12%)	110 (16%)	241 (17%)
12 – 15.9	137 (22%)	160 (23%)	400 (27%)
16 – 19.9	168 (27%)	177 (25%)	417 (29%)
≥ 20	121 (19%)	126 (18%)	186 (13%)

LL — Leukemia, lymphoma & related such as Langerhans cell histiocytosis (LCH)

Solid Tumor – Wilms tumor, neuroblastoma, sarcomas

Other – Thyroid, CNS, nasopharyngeal carcinomas, miscellaneous